Red blood cell alloimmunisation in patients with sickle cell disease

The Lancet Haematology

Volumn 4, Issue 11, 2017, Pages e506-e507

  Volt, Fernanda ^a,b  

^a SAINT LOUIS HOSPITAL   (France)

^b CENTRE SCIENTIFIQUE DE MONACO   (Monaco)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOIMMUNIZATION; ANTIGEN SPECIFICITY; ERYTHROCYTE TRANSFUSION; GENOTYPE; HEMATOPOIETIC STEM CELL; HUMAN; IRON OVERLOAD; MORBIDITY; MORTALITY; NONMYELOABLATIVE CONDITIONING; NOTE; PRIORITY JOURNAL; SICKLE CELL ANEMIA; TREATMENT OUTCOME; ERYTHROCYTE;

ANEMIA, SICKLE CELL; ERYTHROCYTES; HUMANS;

EID: 85042141974     PISSN: None     EISSN: 23523026     Source Type: Journal    
DOI: 10.1016/S2352-3026(17)30198-9     Document Type: Note

References (10)

1. Allen, ES, Srivastava, K, Hsieh, MM, et al. Immunohaematological complications in patients with sickle cell disease undergoing hematopoietic progenitor cell transplantation: a prospective, single-centre, observational study. Lancet Haematol 4 (2017), e508–e516.
2. Hsieh, MM, Fitzhugh, CD, Tisdale, JF, Allogeneic hematopoietic stem cell transplantation for sickle cell disease: the time is now. Blood 118 (2011), 1197–1207.
3. Chou, ST, Transfusion therapy for sickle cell disease: a balancing act. Hematology Am Soc Hematol Educ Program 2013 (2013), 439–446.
4. Aygun, B, Padmanabhan, S, Paley, C, Chandrasekaran, V, Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion 42 (2002), 37–43.
5. Miller, ST, Kim, HY, Weiner, DL, et al. Red blood cell alloimmunization in sickle cell disease: prevalence in 2010. Transfusion 53 (2013), 704–709.
6. Hoppe, C, Klitz, W, Vichinsky, E, Styles, L, HLA type and risk of alloimmunization in sickle cell disease. Am J Hematol 84 (2009), 462–464.
7. Yazdanbakhsh, K, Ware, RE, Noizat-Pirenne, F, Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management. Blood 120 (2012), 528–537.
8. Gluckman, E, Cappelli, B, Bernaudin, F, et al. Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation. Blood 129 (2017), 1548–1556.
9. Scheunemann, LP, Ataga, KI, Delayed hemolytic transfusion reaction in sickle cell disease. Am J Med Sci 339 (2010), 266–269.
10. Meinderts, SM, Sins, JWR, Fijnvandraat, K, et al. Non-classical FCGR2C haplotype is associated with protection from red blood cell allo-immunization in sickle cell disease. Blood, 2017 published online Sept 12. DOI:10.1182/blood-2017-05-784876.